Topic: animal drugs


Animal biotech drug labels are about to get more detailed

The USDA plans to hold manufacturers of veterinary biotech drugs to new, strict standards on labeling. Although companies will have between four and six years to comply, the changes will ultimately help clarify treatment risks and benefits for veterinarians, pet owners and food producers.
Dog with arthritis

One new product on the market, two to go for Aratana

Aratana Therapeutics reached a major milestone on October 5 with its injectable pain reliever Nocita--one of three drugs it won FDA approval for this year--now on the market. But investors are expecting major revenue contributions from the other two products.

Aratana scores third FDA approval of the year

Shares of Aratana Therapeutics rose more than 3% to $9.75 in after-hours trading on August 15, when the company announced that the FDA approved Nocita (bupivacaine), its long-acting injectable drug to relieve pain in dogs after ligament surgery.